BibTex RIS Cite

Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides

Year 2017, Volume: 21 Issue: 2, 306 - 310, 11.05.2017
https://doi.org/10.19113/sdufbed.12478

Abstract

In this study, eight possible stable conformers of the Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) dipeptides, which show the most significant inhibition in cervical carcinoma cells opposite to HT-29 and MCF-7 cells, performed depending on the obtained conformational analysis. The possible stable geometries were determined with the aid of φ, Ψ backbone and c chain dihedral angles. Available all conformers and their energies were calculated and made comparison with the quantum chemical ab-initio results. The Van der Waals, electrostatic , torsional , interaction energies between side and main chains of aminoacids and total energies of cysteine containing dipeptides were computed by using Fortran program.

References

  • [1] McCleland, K., Milne, P. J., Lucieto, F. R., Frost, C., Brauns, S. C., Venter, M., Du Plessis, J., Dyason, K. 2004. An investigation into the biological activity of the selected histidine‐containing diketopiperazines cyclo (His‐Phe) and cyclo (His‐Tyr). Journal of pharmacy and pharmacology, 56(9), 1143-1153.
  • [2] Thundimadathil, J. 2012. Cancer treatment using peptides: current therapies and future prospects. Journal of amino acids,2012.
  • [3] Grant GD. 2002. The Medicinal Chemistry of cyclo(Trp-Trp), cyclo(Gly-Trp) and cyclo(Gly-Gly). University of Port Elizabeth, PhD. thesis.
  • [4] Graz, C. J. M., Grant, G. D., Brauns, S. C., Hunt, A., Jamie, H., & Milne, P. J. 2000. Cyclic dipeptides in the induction of maturation for cancer therapy. Journal of pharmacy and pharmacology, 52(1), 75-82.
  • [5] Jones S. 2002. The Medicinal Chemistry of the Cyclic Dipeptides cyclo (Met-Trp) and cyclo (Met-Tyr). University of Port Elizabeth, MSc dissertation.
  • [6] Khan, D. R., Webb, M. N., Cadotte, T. H., & Gavette, M. N. 2015. Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer. Breast cancer: basic and clinical research, 9(Suppl 2), 1.
  • [7] Kelly, K., Alencar, H., Funovics, M., Mahmood, U., & Weissleder, R. 2004. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer research, 64(17), 6247-6251.
  • [8] Mandelin, J., Cardó-Vila, M., Driessen, W. H., Mathew, P., Navone, N. M., Lin, S. H., Logothetis, C. J., Rietz, A. C., Dobroff, A. S., Proneth, B., Sidman, R. L, Pasqualini, R., Arap, W. 2015. Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors. Proceedings of the National Academy of Sciences, 112(12), 3776-3781.
  • [9] Van der Merwe, E., Huang, D., Peterson, D., Kilian, G., Milne, P. J., Van de Venter, M., & Frost, C. 2008. The synthesis and anticancer activity of selected diketopiperazines. Peptides, 29(8), 1305-1311.
  • [10] Popov, E. M. 1985. An approach to the problem of the structuro-functional organization of natural peptides. Molekuliarnaia biologiia, 19(4), 1107-1138.
  • [11] Popov, E. M., Godjaev, N. M., Ismailova, L. I., Musaev, S. M., Aliev, R. E., Akhmedov, N. A., & Maksumov, I. S. 1982. A-Priori calculation of spatial structure of bovine pancreatic trypsin-inhibitor. Bioorganicheskaya khimiya, 8(6), 776-816.
  • [12] Maksumov, I. S., Ismailova, L. I., & Godjaev, N. M. 1983. The program for semiempirical calculation of conformations of the molecular complexes. J. Struc. Chem.(in Russian), 24, 147.
  • [13] M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, V.G. Zakrzewski, J.A. Montgomery, R.E. Stratmann, J.C. Burant, S. Dapprich, J.M. Millam, A.D. Daniels, K.N. Kudin, M.C. Strain, O. Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi, B. Mennucci, C. Pomelli, C. Adamo, S. Clifford, J. Ochterski, G.A. Petersson, P.Y. Ayala, Q. Cui, K. Morokuma, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J. Cioslowski, J.V. Ortiz, A.G. Baboul, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. Gomperts, R.L. Martin, D.J. Fox, T. Keith, C.Y. M.A. Al-Laham, A. Peng, M. Nanayakkara, P.M.W. Challacombe, B. Gill, W. Johnson, M.W. Chen, J.L. Wong, C. Andres, M. Gonzalez, E.S. Head-Gordon, J.A. Replogle, Gaussian 03, Revision B.04, Gaussian Inc., Pittsburgh, PA, 2003.
  • [14] Becke, A. D. 1993. Density‐functional thermochemistry. III. The role of exact exchange. The Journal of chemical physics, 98(7), 5648-5652.
  • [15] Corey, R. B. 1938. The crystal structure of diketopiperazine. Journal of the American Chemical Society, 60(7), 1598-1604.
  • [16] Degeilh, R., & Marsh, R. E. 1959. A refinement of the crystal structure of diketopiperazine (2, 5-piperazinedione). Acta Crystallographica, 12(12), 1007-1014.
  • [17] Dorset, D. L. 2010. Direct methods and refinement in electron and X-ray crystallography–diketopiperazine revisited. Zeitschrift für Kristallographie International journal for structural, physical, and chemical aspects of crystalline materials, 225(2-3), 86-93.
Year 2017, Volume: 21 Issue: 2, 306 - 310, 11.05.2017
https://doi.org/10.19113/sdufbed.12478

Abstract

References

  • [1] McCleland, K., Milne, P. J., Lucieto, F. R., Frost, C., Brauns, S. C., Venter, M., Du Plessis, J., Dyason, K. 2004. An investigation into the biological activity of the selected histidine‐containing diketopiperazines cyclo (His‐Phe) and cyclo (His‐Tyr). Journal of pharmacy and pharmacology, 56(9), 1143-1153.
  • [2] Thundimadathil, J. 2012. Cancer treatment using peptides: current therapies and future prospects. Journal of amino acids,2012.
  • [3] Grant GD. 2002. The Medicinal Chemistry of cyclo(Trp-Trp), cyclo(Gly-Trp) and cyclo(Gly-Gly). University of Port Elizabeth, PhD. thesis.
  • [4] Graz, C. J. M., Grant, G. D., Brauns, S. C., Hunt, A., Jamie, H., & Milne, P. J. 2000. Cyclic dipeptides in the induction of maturation for cancer therapy. Journal of pharmacy and pharmacology, 52(1), 75-82.
  • [5] Jones S. 2002. The Medicinal Chemistry of the Cyclic Dipeptides cyclo (Met-Trp) and cyclo (Met-Tyr). University of Port Elizabeth, MSc dissertation.
  • [6] Khan, D. R., Webb, M. N., Cadotte, T. H., & Gavette, M. N. 2015. Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer. Breast cancer: basic and clinical research, 9(Suppl 2), 1.
  • [7] Kelly, K., Alencar, H., Funovics, M., Mahmood, U., & Weissleder, R. 2004. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer research, 64(17), 6247-6251.
  • [8] Mandelin, J., Cardó-Vila, M., Driessen, W. H., Mathew, P., Navone, N. M., Lin, S. H., Logothetis, C. J., Rietz, A. C., Dobroff, A. S., Proneth, B., Sidman, R. L, Pasqualini, R., Arap, W. 2015. Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors. Proceedings of the National Academy of Sciences, 112(12), 3776-3781.
  • [9] Van der Merwe, E., Huang, D., Peterson, D., Kilian, G., Milne, P. J., Van de Venter, M., & Frost, C. 2008. The synthesis and anticancer activity of selected diketopiperazines. Peptides, 29(8), 1305-1311.
  • [10] Popov, E. M. 1985. An approach to the problem of the structuro-functional organization of natural peptides. Molekuliarnaia biologiia, 19(4), 1107-1138.
  • [11] Popov, E. M., Godjaev, N. M., Ismailova, L. I., Musaev, S. M., Aliev, R. E., Akhmedov, N. A., & Maksumov, I. S. 1982. A-Priori calculation of spatial structure of bovine pancreatic trypsin-inhibitor. Bioorganicheskaya khimiya, 8(6), 776-816.
  • [12] Maksumov, I. S., Ismailova, L. I., & Godjaev, N. M. 1983. The program for semiempirical calculation of conformations of the molecular complexes. J. Struc. Chem.(in Russian), 24, 147.
  • [13] M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, V.G. Zakrzewski, J.A. Montgomery, R.E. Stratmann, J.C. Burant, S. Dapprich, J.M. Millam, A.D. Daniels, K.N. Kudin, M.C. Strain, O. Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi, B. Mennucci, C. Pomelli, C. Adamo, S. Clifford, J. Ochterski, G.A. Petersson, P.Y. Ayala, Q. Cui, K. Morokuma, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J. Cioslowski, J.V. Ortiz, A.G. Baboul, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. Gomperts, R.L. Martin, D.J. Fox, T. Keith, C.Y. M.A. Al-Laham, A. Peng, M. Nanayakkara, P.M.W. Challacombe, B. Gill, W. Johnson, M.W. Chen, J.L. Wong, C. Andres, M. Gonzalez, E.S. Head-Gordon, J.A. Replogle, Gaussian 03, Revision B.04, Gaussian Inc., Pittsburgh, PA, 2003.
  • [14] Becke, A. D. 1993. Density‐functional thermochemistry. III. The role of exact exchange. The Journal of chemical physics, 98(7), 5648-5652.
  • [15] Corey, R. B. 1938. The crystal structure of diketopiperazine. Journal of the American Chemical Society, 60(7), 1598-1604.
  • [16] Degeilh, R., & Marsh, R. E. 1959. A refinement of the crystal structure of diketopiperazine (2, 5-piperazinedione). Acta Crystallographica, 12(12), 1007-1014.
  • [17] Dorset, D. L. 2010. Direct methods and refinement in electron and X-ray crystallography–diketopiperazine revisited. Zeitschrift für Kristallographie International journal for structural, physical, and chemical aspects of crystalline materials, 225(2-3), 86-93.
There are 17 citations in total.

Details

Journal Section Articles
Authors

Sefa Celık

Serda Kecel Gunduz

Publication Date May 11, 2017
Published in Issue Year 2017 Volume: 21 Issue: 2

Cite

APA Celık, S., & Kecel Gunduz, S. (2017). Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 21(2), 306-310. https://doi.org/10.19113/sdufbed.12478
AMA Celık S, Kecel Gunduz S. Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides. J. Nat. Appl. Sci. August 2017;21(2):306-310. doi:10.19113/sdufbed.12478
Chicago Celık, Sefa, and Serda Kecel Gunduz. “Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 21, no. 2 (August 2017): 306-10. https://doi.org/10.19113/sdufbed.12478.
EndNote Celık S, Kecel Gunduz S (August 1, 2017) Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 21 2 306–310.
IEEE S. Celık and S. Kecel Gunduz, “Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides”, J. Nat. Appl. Sci., vol. 21, no. 2, pp. 306–310, 2017, doi: 10.19113/sdufbed.12478.
ISNAD Celık, Sefa - Kecel Gunduz, Serda. “Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 21/2 (August 2017), 306-310. https://doi.org/10.19113/sdufbed.12478.
JAMA Celık S, Kecel Gunduz S. Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides. J. Nat. Appl. Sci. 2017;21:306–310.
MLA Celık, Sefa and Serda Kecel Gunduz. “Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi, vol. 21, no. 2, 2017, pp. 306-10, doi:10.19113/sdufbed.12478.
Vancouver Celık S, Kecel Gunduz S. Conformational Analysis of Cyclo(Tyr-Cys) and Cyclo(Phe-Cys) Dipeptides. J. Nat. Appl. Sci. 2017;21(2):306-10.

e-ISSN :1308-6529
Linking ISSN (ISSN-L): 1300-7688

All published articles in the journal can be accessed free of charge and are open access under the Creative Commons CC BY-NC (Attribution-NonCommercial) license. All authors and other journal users are deemed to have accepted this situation. Click here to access detailed information about the CC BY-NC license.